If Bass does convert into shares, and there seems to me there's no other more attractive or feasible option (except to voluntarily extend the repayment deadline), it's not all bad.I would do exactly that in Bass's shoes.And I wouldn't flood the market with them, as happens after many CRs.In fact I'd hold and be keen to increase their value, for the ultimate bonanza.
I still assume Bass is convinced of the ultimate value of this project, as I am.
A transformatory Ann could well be in the pipeline. And a string of useful news and monetisation.
Were very much riding on Bass"s beast here.
Though he'll have scored a scorcher with 4c shares in this case, ultimately we win together.
- Forums
- ASX - By Stock
- EM2
If Bass does convert into shares, and there seems to me there's...
Featured News
Add EM2 (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.1¢ |
Change
-0.001(2.38%) |
Mkt cap ! $16.10M |
Open | High | Low | Value | Volume |
4.3¢ | 4.3¢ | 4.1¢ | $38.05K | 922.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 137500 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 61072 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 137500 | 0.040 |
1 | 61000 | 0.039 |
2 | 90000 | 0.038 |
1 | 12000 | 0.037 |
2 | 24300 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.041 | 61072 | 1 |
0.042 | 257340 | 1 |
0.043 | 108535 | 1 |
0.044 | 76825 | 1 |
0.045 | 20001 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
EM2 (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online